Hemolytic anemia associated with dapsone PCP prophylaxis in GBM patients with normal G6PD activity
Neuro Oncol
.
2020 Jun 9;22(6):892-893.
doi: 10.1093/neuonc/noaa026.
Authors
Lisa R Rogers
1
,
Peter Oppelt
2
,
Lalitha Nayak
3
Affiliations
1
Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
2
Washington University, St Louis Siteman Cancer Center, St Peters, Missouri.
3
Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
PMID:
32047930
PMCID:
PMC7283030
DOI:
10.1093/neuonc/noaa026
No abstract available
Keywords:
dapsone; glioblastoma; hemolytic anemia.
Publication types
Letter
MeSH terms
Anemia, Hemolytic* / chemically induced
Anemia, Hemolytic* / prevention & control
Dapsone* / adverse effects
Humans
Substances
Dapsone